PDFファイル
Contents
1. PPD He 1 lt 7 HIV HBV HCV2. PSAI 21700AMY00117000 L2KPF2 2000 xx 2000XPi 1 2 3 4 5 6 SITET TS KEV
3. 8 9 El EE bb Be 1 0 3ng mL 12ng mL 12ng mL 2 EHETE 3 e 4 0 07 25ng mL 0 02ng mL
4. Vd BERRIES SC EMBO e FIK BEINE ERTE Soma 2 8 48 20 2 2000 200mg L A 3 000mg qdL EEE A L2M2Z 30 L mL 2013 4
5. 16X 00mm 2 8 30 20 6 7 2000 L2PWSM 2 PSA 3 h 37 50 4 2 3 37 30 PPD 200 xL 37 5 5 LPFZ 2000 2000XPi 25 L 50 WL 1 30 L H
6. 5 wi LY 6 PSA PSA PSA PSA gt es HAMA HAMA 7 9
7. PSA LD L H 2 5 1 2 Low High 1 2 ng mL 1 000 20 70 425 95 22 64 40
8. 1 000 ppm 1 2 2 121 C 20 dy 0 1 1 3 SIT Pe BES 4 1 2 8C 2 1 Tr amp L2KPF2 200 1 6 200
9. 2 8 90 4 L H 1 3 0mL 2 8 30 20 6 TH 5 PPD 15 28C 20 15 28 30 6 2 2000 L2M2Z
10. ALP EJ A ALP 1 PSA ALP 2 1 2 3 2 75 PPD 2 ALP PSA 3 EL ORES 1 2 3 4 5 6 7 8 2 1 2 3 ae PSA 4 4 3 PPD PSA J ES PSA 1 25 250 275 wLO
11. 1 PSA 2 3 ALP PSA 4 L Di H 6 PPD 4 4 3 1 2 3 2 PSA BER 2 HERA PSA CLEIA PSA PSA PSA 1 a ALP
12. C V 3 2 5 5 0 3ng mL 10 1 20 5 C V 15 10 000ng mL 1 2 2 20 40 80 C V 3 3 6 1 0 09 20ng mL 83 110 1 n 54 r 0 997 y 1 02 x 0 06 2 1000 y 0 07 25ng mL n 184 r 0 998 y 1 04x 0 08 2 37ng mL 2 35ng mL 1000 y AIK 7 15 SST Em ME N EDTA os ANY gt m1 1 04 0 19ng mL r 0 99
13. n 425 0 14ng mL 95 0 42ng mL 2 PSA 4 1 1 0ng mL t PSA PSA 2 f tk 0 15 0 15 Heel ee 1 PSA 2 3 4 9 PSA PSA PSA
14. 11 5mL X 1 1 11 5mL x 1 1 L 3 0mL X 1 3 H 3 0mL X 1 3 L2SUBM PPD 205mL X 2 1 MEE 1 Jacobs DS Grady HD editors Laboratory Test Handbook 4th ed Hudson Cleveland Lexi Comp Inc 1996 193 2 3 Kuriyama M et al Jpn J Clin Oncol 28 661 665 1998 Kuriyama M et al Quantitation of prostate specific antigen in serum by a sensitive enyzme immunoassay Cancer Res 1980 40 4658 62 4 Stamey TA Yang N et al Prostate specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 1987 317 909 16 5 Morgan WR et al Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate impact of adjuvant treatment hormonal and radiation J Urol 1991 145 319 23 6 Primus FJ et al Sandwich type immunoassay of carcinoembryonic antigen in patients receiving murine antibody for diagnosis and therapy Clin Chem 1988 34 261 4 7 Hansen HJ et al Solving the problem of antibody interference in commercial sandwich type immunoassay of carcinoembryonic antigen Clin chem 1989 35 146 51 8 Schroff RJ et al Human anti murine immunoglobulin responses in patients receiving monoclonal antibody therapy Cancer Res 1985 45 879 85 9 Boscato LM Stuart MC H
15. 4 2011 2 3 3 w AFP 10 000 ng mL ND HARA VE PES UE CEA 100 ng mL ND FLEURY 10 000 ng mL ND k hREHETI ER hOEY HCG 100 000 mIU mL ND 10 000 000 ng mL ND PAP 1 000 ng mL ND 200 ng mL ND ND 4 2000 2000XPi 1 1 2 8 90 2 2 8 3
16. 7 EDTA m1 1 03 0 19ng mL r 0 998 SST 1 08 0 28n8g mL r 0 99 37ng mL NISY hni 37ng mL EDTAMMFE 38ng mL SST 36ng m 8 WHO NIBC Ist IS 96 668 1 1 E 2 3 2 1 HIV HIV 1 2 HBs HICV a HBV HCV 2 3 1 2 3 4 4 5 6 3 0 1
17. eterophilic antibodies a problem for all immunoassays Clin Chem 1988 34 27 33 10 11 23 3 199 201 1998 12 31 1 8 1987 13 22 42 48 1993 14 35 1519 1528 1989 15 43 855 860 1997 16 11 639 643 1998 17 13 157 161 1998 18 Maeda H et al Acta Urol Jpn 44 307 311 1998 19 Maeda H et al Int J Urol 5 343 348 1998 20 Sumi S et al PHA YW 60 602 606 1998 03 3493 8400 1 11 1 10380984M1_03 PINL2KPF 5 21 2009 05 21
Download Pdf Manuals
Related Search